Pimavanserin Impurity 50 CAS CATO-C4X-193850
| CAS No. | CATO-C4X-193850 |
| Molecular Formula | C19H30FN3 |
| Molecular Weight | 319.46 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
Pimavanserin Impurity 50 (CAS CATO-C4X-193850) is a certified pharmaceutical impurity reference standard with the molecular formula C19H30FN3 and a molecular weight of 319.46 g/mol.
Owing to a nitrogen-containing heterocyclic scaffold, a nitrile group, fluorine substitution, Pimavanserin Impurity 50 is typically off-white to pale yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 319.46 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
CATO manufactures Pimavanserin Impurity 50 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C19H30FN3 |
| Molecular Weight | 319.46 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related Pimavanserin Standards
- Pimavanserin Impurity 27 (CAS CATO-C4X-193827)
- Pimavanserin Impurity 14 (CAS CATO-C4X-193814)
- Pimavanserin Impurity 19 (CAS CATO-C4X-193819)
- Pimavanserin Impurity 36 (CAS 1983947-08-5)
- Pimavanserin Impurity 40 (CAS CATO-C4X-193840)
- Pimavanserin Impurity 67 (CAS CATO-C4X-193867)
- Pimavanserin Impurity 12 (CAS CATO-C4X-193812)
- Pimavanserin Impurity 2 (CAS 103907-97-7)
Recommended Standards
- 4-(Tert-butyl)-N-(4-methylpiperazine-1-carbonothioyl)benzamide (CAS 497060-60-3)
- Boc-O-(tert-butyldimethylsilyl)-D-serine (CAS 123254-10-4)
- (triphenylphosphine)acetonitrile (CAS 16640-68-9)
- 2-Chloro-5-(difluoromethyl)-6-iodo-3-methoxypyridine (CAS 1804495-56-4)
- Afatinib Impurity 26 (CAS CATO-C4X-100626)
- Carfilzomib Impurity 10 (CAS CATO-C4X-102210)
- Duloxetine Impurity 23 (CAS CATO-C4X-133623)
- 3-Cyclohexyl-1-(1,2,3,4-tetrahydroquinolin-5-yl)urea (CAS 1016743-88-6)
- 2-((1R,3R)-3-Hydroxy-3-methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)isoindoline-1,3-dione (CAS 1199556-90-5)
- 4-Bromo-3-P-Tolyl-1h-Pyrazol-5-Amine (CAS 201735-19-5)
- 2-(4-Chlorophenoxy)tetrahydro-2H-pyran (CAS 20443-90-7)
- tert-Butyl (2-amino-2-(4-nitrophenyl)ethyl)carbamate (CAS 939760-51-7)
- imidazo[1,2-a]pyrimidin-6-ylboronic acid (CAS 2426692-30-8)
- (D-Tyr1,N-Me-Phe3)-Neuropeptide FF (H-4752.0001) (CAS 145274-93-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com